| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Molecular and cellular mechanisms of general anaesthesia.
|
Nature
|
1994
|
6.94
|
|
2
|
PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.
|
Clin Pharmacol Ther
|
1965
|
2.56
|
|
3
|
Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
|
J Pain Symptom Manage
|
1999
|
1.93
|
|
4
|
New clinical-practice guidelines for the management of pain in patients with cancer.
|
N Engl J Med
|
1994
|
1.70
|
|
5
|
Opioid substitution to reduce adverse effects in cancer pain management.
|
Med J Aust
|
1999
|
1.48
|
|
6
|
Ketamine as an adjunct to morphine in the treatment of pain.
|
Pain
|
1995
|
1.42
|
|
7
|
[Cancer pain: beneficial effect of ketamine addition to spinal administration of morphine-clonidine-lidocaine mixture].
|
Ann Fr Anesth Reanim
|
1996
|
1.41
|
|
8
|
Transporting patients with overwhelming pain.
|
Anaesthesia
|
1994
|
1.39
|
|
9
|
Ketamine-fentanyl-midazolam infusion for the control of symptoms in terminal life care.
|
Am J Hosp Palliat Care
|
2001
|
1.39
|
|
10
|
Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor?
|
Anesthesiology
|
1990
|
1.25
|
|
11
|
Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study.
|
J Pain Symptom Manage
|
2000
|
1.12
|
|
12
|
Continuous subcutaneous injection of ketamine for cancer pain.
|
Can J Anaesth
|
1990
|
1.10
|
|
13
|
Pharmacokinetics and analgesic effect of ketamine in man.
|
Br J Anaesth
|
1981
|
1.09
|
|
14
|
Ketamine as an adjuvant to opioids for cancer pain.
|
Cochrane Database Syst Rev
|
2003
|
1.09
|
|
15
|
Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management.
|
Anesthesiology
|
1999
|
1.08
|
|
16
|
Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain.
|
Can J Anaesth
|
1996
|
1.05
|
|
17
|
Low-dose subcutaneous ketamine infusion and morphine tolerance.
|
Pain
|
1999
|
1.00
|
|
18
|
NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride.
|
Pain
|
1996
|
0.95
|
|
19
|
Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.
|
Pain
|
1994
|
0.94
|
|
20
|
Ketamine attenuates and reverses morphine tolerance in rodents.
|
Anesthesiology
|
1996
|
0.91
|
|
21
|
The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input.
|
Pain
|
1996
|
0.91
|
|
22
|
Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient.
|
J Pain Symptom Manage
|
1995
|
0.90
|
|
23
|
Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation.
|
Neurosurgery
|
1995
|
0.90
|
|
24
|
Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients.
|
J Pain Symptom Manage
|
2002
|
0.84
|
|
25
|
Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization.
|
Pain
|
1995
|
0.84
|
|
26
|
Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo.
|
Clin Neuropharmacol
|
1995
|
0.82
|
|
27
|
"Burst" ketamine for refractory cancer pain: an open-label audit of 39 patients.
|
J Pain Symptom Manage
|
2001
|
0.81
|
|
28
|
Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade.
|
Neurosurgery
|
1997
|
0.81
|
|
29
|
Adjuvant ketamine analgesia for the management of cancer pain.
|
Ann Pharmacother
|
2002
|
0.81
|
|
30
|
Summary version of the Standards, Options and Recommendations for the use of analgesia for the treatment of nociceptive pain in adults with cancer (update 2002).
|
Br J Cancer
|
2003
|
0.79
|
|
31
|
[Standards, options and recommendations for the use of medical analgesics for the treatment of pain arising from excess nociception in adults with cancer (update 2002): opioid analgesics with the exception of morphine by mouth and the rotation].
|
Bull Cancer
|
2003
|
0.77
|
|
32
|
Ketamine for cancer pain.
|
J Pain Symptom Manage
|
2000
|
0.77
|
|
33
|
[Ketamine infusion for control of pain in patients with advanced cancer].
|
Masui
|
1990
|
0.75
|
|
34
|
Pain management: physiopathology, future research and endpoints.
|
Support Care Cancer
|
1993
|
0.75
|